Prevention of VTE in adults who have undergone elective hip or knee replacement surgery. Reduced the risk of stroke, systemic embolism, & death in patients with nonvalvular atrial fibrillation (NVAF) with ≥1 risk factors, including patients unsuitable for warfarin. Treatment & prevention (recurrent) of DVT & pulmonary embolism (PE).